Cargando…

Clinical research of intraperitoneal implantation of sustained-release 5-fluorouracil in advanced colorectal cancer

BACKGROUND: The objective of this study was to investigate the safety and long-term clinical effect of intraperitoneal implantation of sustained-release 5-fluorouracil in patients with advanced colorectal cancer during radical resection. METHODS: A total of 202 patients with advanced colorectal canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Hang, Zheng, Bo’an, Tu, Shiliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657249/ https://www.ncbi.nlm.nih.gov/pubmed/26596801 http://dx.doi.org/10.1186/s12957-015-0737-9

Ejemplares similares

Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: a systematic review and meta-analysis
por: Yuan, Hang, et al.
Publicado: (2017)

Retrospective Cohort Study of Intraoperative Administration of Sustained-Release 5-Fluorouracil Implants in Advanced Gastric Cancer Patients
por: Ge, Jie, et al.
Publicado: (2021)

Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer
por: Tummala, Shashank, et al.
Publicado: (2015)

No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer
por: Wu, Yun-Zi, et al.
Publicado: (2022)

HMGB3 is a Potential Therapeutic Target by Affecting the Migration and Proliferation of Colorectal Cancer
por: Gong, Wenjing, et al.
Publicado: (2022)

Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma.
por: McArdle, C. S., et al.
Publicado: (1994)

Preparation of 5-fluorouracil-loaded chitosan nanoparticles and study of the sustained release in vitro and in vivo
por: Sun, Li, et al.
Publicado: (2017)

Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution.
por: Kerr, D. J., et al.
Publicado: (1996)

Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
por: Chau, I, et al.
Publicado: (2001)

MEIS2 promotes cell migration and invasion in colorectal cancer
por: Wan, Ziang, et al.
Publicado: (2019)

Granuloma induced by sustained-release fluorouracil implants misdiagnosed as a hepatic tumor: A case report
por: BAI, DOU-SHENG, et al.
Publicado: (2014)

Double-Emulsion Copolyester Microcapsules for Sustained Intraperitoneal Release of Carboplatin
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2019)

Application of 5-Fluorouracil-Polycaprolactone Sustained-Release Film in Ahmed Glaucoma Valve Implantation Inhibits Postoperative Bleb Scarring in Rabbit Eyes
por: Bi, Xiu-Zeng, et al.
Publicado: (2015)

Loss of exosomal micro-RNA-200b-3p from hypoxia cancer-associated fibroblasts reduces sensitivity to 5-flourouracil in colorectal cancer through targeting high-mobility group box 3
por: Yuan, Hang, et al.
Publicado: (2022)

Effects of Bolus Injection of 5-Fluorouracil on Steady-State Plasma Concentrations of 5-Fluorouracil in Japanese Patients with Advanced Colorectal Cancer
por: Tamura, Takao, et al.
Publicado: (2011)

Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases.
por: Goldberg, J. A., et al.
Publicado: (1988)

The effect of 5-fluorouracil and alpha interferon and 5-fluorouracil and leucovorin on cellular anti-tumour immune responses in patients with advanced colorectal cancer.
por: Nichols, P. H., et al.
Publicado: (1994)

Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer
Publicado: (2001)

The pharmacokinetics of 5-fluorouracil administered by arterial infusion in advanced colorectal hepatic metastases.
por: Goldberg, J. A., et al.
Publicado: (1990)

Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer
por: Glimelius, B, et al.
Publicado: (2011)

Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
por: Scheithauer, W., et al.
Publicado: (1998)

Continuous infusion of 5-fluorouracil with alpha 2b interferon for advanced colorectal carcinoma.
por: Ferguson, J. E., et al.
Publicado: (1995)

Downregulation of SIRT7 by 5-fluorouracil induces radiosensitivity in human colorectal cancer
por: Tang, Ming, et al.
Publicado: (2017)

Controlled release of 5-fluorouracil and progesterone from magnetic nanoaggregates
por: Ragab, Doaa M, et al.
Publicado: (2012)

Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis
por: Guo, Jian-Hai, et al.
Publicado: (2017)

LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance
por: Ma, Yu-Nan, et al.
Publicado: (2021)

N(3)-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU
por: Zhang, Xiaofan, et al.
Publicado: (2009)

Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study
por: Tomlinson, Shannon K, et al.
Publicado: (2002)

Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis
por: Li, Bo, et al.
Publicado: (2019)

Molecular profile of 5-fluorouracil pathway genes in colorectal carcinoma
por: Kunicka, T., et al.
Publicado: (2016)

CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal Cancer
por: Zhang, Guolin, et al.
Publicado: (2020)

Research Advances in Tissue Engineering Materials for Sustained Release of Growth Factors
por: Zhao, Hai-yang, et al.
Publicado: (2015)

A Novel Class of Antitumor Prodrug, 1‐(2′‐Oxopropyl)‐5‐fluorouracil (OFU001), That Releases 5‐Fluorouracil upon Hypoxic Irradiation
por: Shibamoto, Yuta, et al.
Publicado: (2000)

Downregulation of lncRNA RPLP0P2 inhibits cell proliferation, invasion and migration, and promotes apoptosis in colorectal cancer
por: Yuan, Hang, et al.
Publicado: (2021)

Adjuvant Perioperative Intraperitoneal Chemotherapy in Locally Advanced Colorectal Carcinoma: Preliminary Results
por: Tentes, A. A. K., et al.
Publicado: (2011)

Retraction Note: LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance
por: Ma, Yu-Nan, et al.
Publicado: (2023)

Establishment of patient‐derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5‐fluorouracil
por: Lin, Yu‐Lin, et al.
Publicado: (2019)

5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer
por: Sobrero, A, et al.
Publicado: (2001)

5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer
por: Jodrell, D I, et al.
Publicado: (2001)

Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil
por: Guglielmi, A, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_deiqosclmtclhm7kl2776m56o8